- In May, FDA Commissioner Robert M. Califf, M.D., requested an internal agency review of the FDA’s actions related to multiple reports of Cronobacter in infants, the temporary shutdown of Abbot
Continue Reading FDA Publishes Internal Evaluation of Infant Formula Response